Pandanus

Pandanus tectorius contains flavonoids, phenolics, saponins, terpenoids, and glycosides that drive antioxidant activity via DPPH and hydroxyl radical scavenging, anti-inflammatory action through nitric oxide inhibition in macrophages, and wound healing via TGF-β upregulation. In rat wound-healing studies, topical gels containing 20–30% fruit extract significantly accelerated tissue regeneration compared to controls (p < 0.05), while ethyl acetate core extracts demonstrated antioxidant IC₅₀ values as low as 0.8 μg/mL in DPPH assays.

Category: Pacific Islands Evidence: 1/10 Tier: Preliminary
Pandanus — Hermetica Encyclopedia

Origin & History

Pandanus tectorius, commonly called screwpine, is native to the Pacific Islands, Southeast Asia, and coastal regions of the Indian Ocean, thriving in sandy, saline soils along shorelines, atolls, and low-lying tropical coastlines. The plant is cultivated extensively throughout Micronesia, Polynesia, and Melanesia, where it serves as a critical food security crop, with its fruit keys, leaves, aerial roots, and flowers used across generations. It grows as a branching tree or shrub reaching up to 15 meters, producing dense clusters of aggregate fruits that ripen to orange or red hues and are harvested year-round in tropical climates.

Historical & Cultural Context

Pandanus tectorius, known as hala in Hawaiian and bob in Marshallese, has been a foundational plant in Pacific Islander cultures for over three thousand years, serving simultaneously as food, medicine, building material, and ceremonial object across Micronesian, Polynesian, and Melanesian societies. In Micronesian traditional medicine, aerial roots are decocted and consumed for urinary tract conditions and general debility, while fruit keys are chewed or applied topically for wound care and skin ailments, uses that align with the plant's now-confirmed phenolic and flavonoid content. In Polynesian traditions, particularly in the Cook Islands and Tonga, floral bracts and young leaves are used in poultices for headaches, fevers, and infected wounds, with preparations passed down through family-based healing lineages rather than formal pharmacopoeias. The plant's cultural significance extends beyond medicine into nutrition and survival, as dried and fermented fruit keys called 'breadfruit of the atolls' provided critical caloric sustenance during periods of drought and inter-island voyaging.

Health Benefits

- **Antioxidant Protection**: Phenolics and flavonoids in fruit and floral extracts scavenge DPPH and hydroxyl radicals, with phenolic-rich extracts achieving IC₅₀ values of 76.4 μg/mL (DPPH) and 62.5 μg/mL (hydroxyl radical), and floral extracts reaching a total phenolic content of 346.65 ± 0.30 mg/g GAE.
- **Wound Healing Acceleration**: Flavonoids in fruit extracts upregulate transforming growth factor-beta (TGF-β), stimulating epithelial cell proliferation and tissue regeneration; rat model studies confirmed 20–30% topical gels produced statistically significant wound closure versus untreated controls (p < 0.05).
- **Anti-Inflammatory Activity**: Saponin-rich extracts suppress LPS-induced nitric oxide production in RAW 264.7 macrophages, reducing inflammatory signaling cascades, though high concentrations reduce macrophage cell survival to approximately 64.3%, indicating a narrow therapeutic window.
- **Antibacterial Action**: Phenolics, flavonoids, and steroids from key and core extracts inhibit the growth of Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, with inhibition zones ranging from 10–15 mm in disc diffusion assays.
- **Anticancer Potential (Preliminary)**: Self-nanoemulsifying drug delivery systems (SNEDDS) formulated from leaf extracts have been investigated for enhanced bioavailability of cytotoxic constituents, with in vitro screening showing low cytotoxicity against MCF-7, HeLa, and HepG2 cell lines at doses below 30–40 μg/mL.
- **Broad Phytochemical Richness for Metabolic Support**: Ethanol extracts contain substantial flavonoids (169.48 mg/mL), terpenoids (12.76 mg/mL), and alkaloids (12.24 mg/mL), compounds associated with enzyme inhibition and cellular signaling modulation, though specific metabolic endpoints in humans remain unstudied.
- **Traditional Wound and Skin Care**: Aerial roots and fruit preparations have been used medicinally across Micronesian and Polynesian communities for treating incisions and topical infections, a traditional application now supported by preliminary in vitro and in vivo antibacterial and wound-healing data.

How It Works

Phenolics and flavonoids exert antioxidant effects by donating hydrogen atoms to neutralize DPPH and hydroxyl free radicals, with phenolics identified as the primary contributors to radical scavenging capacity in fruit extracts (IC₅₀ = 76.4 μg/mL DPPH). Saponin-rich fractions inhibit LPS-stimulated nitric oxide production in RAW 264.7 macrophages, likely through suppression of inducible nitric oxide synthase (iNOS) expression downstream of NF-κB signaling, though cytotoxicity at high saponin concentrations constrains the therapeutic dose range. Flavonoids promote wound healing by upregulating TGF-β, a cytokine central to fibroblast recruitment and epithelial cell proliferation, while tannins, alkaloids, and phenolics provide concurrent anti-inflammatory and antimicrobial support to the wound microenvironment. Antibacterial constituents including phenolics, flavonoids, and steroids disrupt bacterial cell membrane integrity and inhibit cell wall biosynthesis in both gram-positive (B. subtilis, S. aureus) and gram-negative (E. coli, P. aeruginosa) organisms, as evidenced by inhibition zones of 10–15 mm in agar diffusion studies.

Scientific Research

The evidence base for Pandanus tectorius is confined to in vitro cell culture studies and a small number of in vivo animal experiments, with no published human clinical trials identified as of the most recent search. Antioxidant and phytochemical characterization studies using DPPH, hydroxyl radical, and Folin-Ciocalteu assays provide reproducible quantitative data on phenolic and flavonoid content across plant parts, including floral extracts with TPC of 346.65 ± 0.30 mg/g GAE and TFC of 143.29 ± 0.22 mg/g QE. Wound-healing efficacy was assessed in a rat excision model using 20% and 30% fruit extract gels, showing statistically significant tissue regeneration versus controls (p < 0.05), though no difference was observed between the two concentrations (p = 0.717), limiting dose-optimization conclusions. Cytotoxicity screening across RAW 264.7, L-6, MCF-7, HeLa, and HepG2 cell lines generally showed IC₅₀ values above 30 μg/mL, supporting a preliminary safety profile, but the overall evidence quality is low due to absence of randomized controlled trials, standardized extract formulations, and human pharmacokinetic data.

Clinical Summary

No human clinical trials have been conducted on Pandanus tectorius in any medicinal capacity, meaning all clinical inferences are extrapolated from in vitro and limited animal data. The most substantive in vivo evidence comes from a rat wound-healing study in which topical 20–30% fruit extract gels significantly accelerated tissue regeneration versus untreated controls (p < 0.05), though the study did not specify animal sample size or employ blinding protocols, reducing confidence in the finding. Anti-inflammatory and antioxidant outcomes have been measured exclusively in cell culture systems (RAW 264.7 macrophages, DPPH radical assays), providing mechanistic plausibility but no translational dose or efficacy data for humans. Until randomized controlled trials with defined extract standardization, dosing protocols, and human safety monitoring are completed, Pandanus tectorius must be classified as a preliminary-evidence botanical with promising but unconfirmed therapeutic potential.

Nutritional Profile

Pandanus tectorius fruit keys provide carbohydrates as the dominant macronutrient, with the edible mesocarp containing starchy polysaccharides that historically served as a staple caloric source in low-resource atoll environments. Micronutrient analysis of fruit and seed components shows the presence of provitamin A carotenoids, vitamin C, and iron, though precise concentrations vary substantially by ripeness stage and geographic ecotype. Phytochemically, floral extracts are the richest fraction with total phenolic content of 346.65 ± 0.30 mg/g GAE and total flavonoid content of 143.29 ± 0.22 mg/g QE; ethanol fruit extracts contain flavonoids at 169.48 mg/mL, terpenoids at 12.76 mg/mL, alkaloids at 12.24 mg/mL, and trace saponins at 0.053 mg/mL. Bioavailability of polyphenols from whole fruit preparations is expected to be moderate, with lipophilic terpenoids and steroids potentially benefiting from co-consumption with dietary fat, and the SNEDDS nanoemulsion formulation being developed specifically to improve solubility and absorption of hydrophobic actives.

Preparation & Dosage

- **Topical Gel (Wound Healing)**: 20–30% fruit extract gel applied directly to wounds; rat model studies used these concentrations with statistically significant effect versus controls, with no added benefit observed above 20%.
- **Ethanol Extract (Research Standard)**: Prepared via Box-Behnken optimized extraction using ethanol concentration, temperature, solvent-to-material ratio, and extraction time to maximize phenolic and saponin yield; dominant actives include flavonoids at 169.48 mg/mL and terpenoids at 12.76 mg/mL.
- **Ethyl Acetate Fraction**: Derived from keys and cores; demonstrates strongest antioxidant activity (IC₅₀ = 0.8 ± 0.20 mg/mL DPPH) and is used in antibacterial research.
- **Self-Nanoemulsifying Drug Delivery System (SNEDDS)**: Experimental formulation from leaf extracts using 3 g total formulation with 100 mg active compounds; not yet optimized or commercially available.
- **Traditional Preparations**: Roots and fruit cores prepared as decoctions or poultices in Micronesian and Polynesian traditional medicine; no standardized preparation protocol has been formally documented.
- **Human Supplemental Dose**: No established oral supplemental dose exists; all dosing data are derived from in vitro or animal studies and cannot be directly applied to human use.

Synergy & Pairings

Pandanus tectorius phenolics and flavonoids are likely to exhibit additive or synergistic antioxidant activity when combined with other polyphenol-rich botanicals such as green tea catechins (EGCG) or turmeric curcuminoids, as multiple radical scavenging mechanisms acting through hydrogen donation, metal chelation, and electron transfer are complementary rather than redundant. The saponin-mediated anti-inflammatory activity targeting iNOS and NO production may be potentiated by curcumin's NF-κB inhibition, creating a dual-pathway suppression of the LPS-inflammatory cascade relevant to wound and immune applications. For wound-healing formulations, combination of Pandanus flavonoids (TGF-β upregulation) with aloe vera polysaccharides (extracellular matrix hydration and fibroblast proliferation) represents a mechanistically rational topical stack, though no co-formulation studies have yet been published.

Safety & Interactions

At low-to-moderate concentrations, Pandanus tectorius extracts demonstrate acceptable cytotoxicity profiles, with IC₅₀ values exceeding 30–40 μg/mL against RAW 264.7, L-6, MCF-7, HeLa, and HepG2 cell lines; however, high-concentration saponin-rich fractions reduce macrophage cell viability to approximately 64.3%, indicating a dose-dependent cytotoxicity risk that must be considered in any formulation development. No drug interactions have been formally studied or reported, and no contraindications have been established based on available literature, though the plant's saponin content warrants caution in combination with drugs that affect cell membrane permeability or gastrointestinal mucosal integrity. No human safety data, maximum tolerated doses, or pharmacovigilance records are available, meaning use in vulnerable populations including pregnant women, lactating mothers, and individuals with hepatic or renal impairment cannot be guided by evidence and should be avoided until clinical safety studies are conducted. Topical application of 20–30% fruit extract gels in animal studies produced no reported adverse tissue reactions, suggesting reasonable local tolerability, but systemic exposure via oral routes remains uncharacterized.